ロード中...
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Up to 18% of patients with acute myeloid leukemia (AML) present with a white blood cell (WBC) count of greater than 100,000/µL, a condition that is frequently referred to as hyperleukocytosis. Hyperleukocytosis has been associated with an adverse prognosis and a higher incidence of life-threatening...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7603052/ https://ncbi.nlm.nih.gov/pubmed/33080779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9102310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|